Search
for
Did you mean Disease-Modifying Antirheumatic Drugs?
Sort by
Research 30 of 1000+
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- 129 Utilizing Polygenic score in predicting the disease activity and arthritis in psoriasis patients
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis
- Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review
- Alopecia Areata: Clinical Treatment
- Diagnostic challenges in determining alopecia areata
- P13 DMARD preconception counselling and reinforcement should be a norm in all rheumatology clinics
- Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study
- THE OCCURRENCE OF DISCOID LUPUS ERYTHROMATOSUS PROGRESSING TO SYSTEMIC LUPUS ERYTHEMATOSUS, WITH OVERLAPPING ANCA-ASSOCIATED VASCULITIS, AND RHEUMATOID ARTHRITIS PRESENTING AS PAPULAR-PURPURIC GLOVE AND SOCK SYNDROME
- 5PSQ-056 Experience with tofacinitib and baricitinib in rheumatoid arthritis
- Effectiveness and safety of physician–pharmacist collaborative care for rheumatoid arthritis patients: The Changi General Hospital’s experience
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Immunosuppressive therapy in autoimmune disease — A review
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Topical delivery of nanoemulsions for skin cancer treatment
- Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
- Hydrogels: current biomedical applications and future directions
- Ethosomes: New Prospects in Transdermal Delivery
- The Potential of Ginkgo biloba as a Source of Biologically Active Compounds—A Review of the Recent Literature and Patents
- Application of Baricitinib in Dermatology
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- New drugs under investigation for the treatment of alopecias
- Cutaneous Drug Reaction Case Reports
- New Drugs: Dutasteride